Olba DVx Healthcare (TSE:2689) ROCE %: 16.81% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2689 Olba DVx Healthcare Inc TSE:2689
62 GF Score
Price 円1,925.00
GF Value 円2,164.52
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Olba DVx Healthcare ROCE %?

Olba DVx Healthcare TSE:2689 62 ROCE % is 16.81% as of Mar. 2026. GuruFocus rates TSE:2689 with a GF Score™ of 62/100 and a GF Value™ of 円2,164.52 (Modestly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Olba DVx Healthcare's annualized ROCE % for the quarter that ended in Mar. 2026 was 16.81%.

Olba DVx Healthcare  (TSE:2689) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Olba DVx Healthcare ROCE % Related Terms

Olba DVx Healthcare ROCE % Historical Data

* Premium members only.

The historical data trend for Olba DVx Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olba DVx Healthcare ROCE % Chart

Olba DVx Healthcare Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.03 18.59 17.54 13.24 11.25

Olba DVx Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.32 6.73 11.60 16.81 10.86
TSE:2689
62GF Score
Olba DVx Healthcare Inc TSE:2689
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Olba DVx Healthcare ROCE % Calculation

Olba DVx Healthcare's annualized ROCE % for the fiscal year that ended in Jun. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2026 )  (A: Jun. 2025 )(A: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2026 )  (A: Jun. 2025 )(A: Jun. 2026 )
=1835.348/( ( (45871.212 - 29821.745) + (46653.564 - 30070.358) )/ 2 )
=1835.348/( (16049.467+16583.206)/ 2 )
=1835.348/16316.3365
=11.25 %

Olba DVx Healthcare's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=2680.536/( ( (48111.991 - 32300.813) + (49360.389 - 33269.748) )/ 2 )
=2680.536/( ( 15811.178 + 16090.641 )/ 2 )
=2680.536/15950.9095
=16.80 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 16.81% mean?
Olba DVx Healthcare (TSE:2689) has a ROCE % of 16.81% as of Mar. 2026.
Is Olba DVx Healthcare's ROCE % too high?
Olba DVx Healthcare's current ROCE % is 16.81%. The Medical Distribution industry median ROCE % is 8.83. Olba DVx Healthcare's value of 16.81% is 90.5% above this industry median. Overall, Olba DVx Healthcare has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olba DVx Healthcare's ROCE % compare to MCK and COR?
Olba DVx Healthcare's ROCE % of 16.81% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 8.83. Olba DVx Healthcare's value of 16.81% is 90.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 8.83, based on 124 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Olba DVx Healthcare's current ROCE % of 16.81% is 90.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 8.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Olba DVx Healthcare's current ROCE % is 16.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olba DVx Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Olba DVx Healthcare (TSE:2689) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,164.52, compared to a current price of 円1,925.00 — trading 11.1% below its estimated fair value. The current ROCE % is 16.81% and 90.5% above the Medical Distribution industry median of 8.83. Olba DVx Healthcare's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Olba DVx Healthcare (TSE:2689), the current ROCE % is 16.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Olba DVx Healthcare (TSE:2689) Overvalued in 2026?

Based on GuruFocus' analysis, Olba DVx Healthcare stock appears to be undervalued. The current stock price of 円1,925.00 is trading 11.1% below its estimated GF Value™ of 円2,164.52. GuruFocus considers Olba DVx Healthcare to be Modestly Undervalued.

Key valuation signals for TSE:2689:

  • ROCE %: 16.81%
  • GF Value™: 円2,164.52 vs. price of 円1,925.00 (11.1% below fair value)
  • GF Score™: 62/100 with 2 warning signs
  • Industry Position: 90.5% above the Medical Distribution median

No single metric tells the full story. See the TSE:2689 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Olba DVx Healthcare Business Description

Address 1-1-3 Shimoishii, Kita-ku, 8th Floor, Nippon Life Insurance Okayama Dai-ni Building, Okayama Prefecture, Okayama, JPN, 700-0907
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
62GF Score

Get the complete analysis for TSE:2689

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,925.00
Price
円2,164.52
GF Value